Helicobacter Pylori Diagnostics Market to Reach $926.8 Million, Globally, by 2032 at 5.3% CAGR | Meridian Bioscience, Inc., Cardinal Health Inc., Thermo Fisher Scientific Inc.

According to the report, the global Helicobacter pylori diagnostics industry generated $552.7 million in 2022, and is anticipated to generate $926.8 million by 2032, witnessing a CAGR of 5.3% from 2023 to 2032.

Download Sample Report-

https://www.alliedmarketresearch.com/request-sample/3543

The global Helicobacter pylori diagnostics market is experiencing growth due to several factors, including the rise in prevalence of infectious diseases, an increase in demand for non-invasive diagnostic procedures, and the development of new and improved testing methods. However, the lack of awareness and shortage of skilled professionals restrict market growth. Moreover, the rise in demand for point-of-care H. pylori testing presents new opportunities in the coming years.

The non-invasive test segment to maintain its leadership status throughout the forecast period:

Based on test type, the non-invasive test segment held the largest market share in 2022, accounting for around three-fifths of the global Helicobacter pylori diagnostics market revenue, and is estimated to maintain its leadership status throughout the forecast period. The same segment would also showcase the highest CAGR of 5.6% from 2023 to 2032. This is due to the high adoption of non-invasive tests, including stool antigen tests, as they provide benefits such as being easy to perform, requiring only a blood or stool sample, and being done without the need for specialized equipment or trained personnel.

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/3543

The laboratory based test segment to dominate in terms of revenue during the forecast period:

Based on method, the laboratory-based test segment held the largest market share in 2022, accounting for more than four-fifths of the global Helicobacter pylori diagnostics market, and is projected to dominate in terms of revenue during the forecast period. The high adoption of laboratory-based tests such as immunoassays is due to their high sensitivity and specificity, which makes them an ideal choice for diagnosing disease, which is a major factor that propels the growth of this segment. However, the point-of-care test segment is expected to witness the fastest CAGR of 6.5% from 2023 to 2032. Point-of-care tests can provide immediate results, which allows faster diagnosis and treatment of conditions such as H. pylori infection, which is expected to drive the growth of the segment.

The diagnostic laboratories segment to maintain its lead position during the forecast period:

Based on end user, the diagnostic laboratories segment accounted for the largest share in 2022, contributing to more than half three-fifths of the global Helicobacter pylori diagnostics market revenue, and is projected to maintain its lead position during the forecast period. The availability of trained medical staff in laboratories and a rise in patient admissions to laboratories for H. pylori testing are expected to contribute to market growth. However, the other segment is expected to portray the fastest CAGR of 6.5% from 2023 to 2032. The rise in demand for non-invasive and user-friendly diagnostic tests and the growing trend towards self-diagnosis and self-treatment are expected to drive the growth of the segment.

For Purchase Inquiry-

https://www.alliedmarketresearch.com/purchase-enquiry/3543

North America to maintain its dominance by 2032:

Based on region, North America held the largest market share in terms of revenue in 2022, accounting for around two-fifths of the global Helicobacter pylori diagnostics market revenue, and is likely to dominate the market during the forecast period. Easy availability of products for the diagnosis of H. pylori bacteria, advanced healthcare infrastructure, and a rise in the adoption of non-invasive methods promoted the growth of the Helicobacter pylori diagnostics market in North America. However, the Asia-Pacific region is expected to exhibit the fastest CAGR of 6.3% from 2023 to 2032. An increase in the prevalence of infectious diseases such as gastric cancer along with growing awareness about early diagnosis is expected to drive the growth of the Helicobacter pylori diagnostics market.

Leading Market Players:

Thermo Fisher Scientific Inc.
Meridian Bioscience, Inc.
Bio-Rad Laboratories, Inc.
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Cardinal Health Inc.
Avanos Medical, Inc.
Gulf Coast Scientific
Quidel Corporation
Biohit Oyj

Trending Reports in Healthcare Sectors:

Intravenous equipment market https://www.alliedmarketresearch.com/intravenous-equipment-market-A10856

Chlorpheniramine Maleate Market https://www.alliedmarketresearch.com/chlorpheniramine-maleate-market

Metastatic Cancer Drugs Market https://www.alliedmarketresearch.com/metastatic-cancer-drugs-market-A109351

Diabetic Foot Ulcer Treatment Market https://www.alliedmarketresearch.com/diabetic-foot-ulcer-treatment-market-A110954

Consumer Healthcare Market https://www.alliedmarketresearch.com/consumer-healthcare-market

Penicillin Drug Market https://www.alliedmarketresearch.com/penicillin-drug-market-A110795

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.